Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Systemic Light Chain Amyloidosis
Vanessa E. Kennedy, Kelsey Natsuhara, Sireesha Asoori Maringanti, Nina Shah, Shagun Arora, Jeffrey L. Wolf, Thomas G. Martin, Mandar A. Aras, Alfred Chung, Sandy W. Wong
Topics & Concepts
DaratumumabMedicineAL amyloidosisBortezomibInternal medicinePlasma cell dyscrasiaRegimenDexamethasoneMultiple myelomaAmyloidosisCyclophosphamideGastroenterologyOncologyImmunologyChemotherapyImmunoglobulin light chainAntibodyAmyloidosis: Diagnosis, Treatment, OutcomesMyeloproliferative Neoplasms: Diagnosis and TreatmentCoagulation, Bradykinin, Polyphosphates, and Angioedema